APPI Bulletin - August 2008

If this page doesn't display properly in your email, click here.

August 2008


APPI Home Career Center Code of Ethics Regional Chapters Events Calendar Readings, Resources, & Events of Interest The Academy and APPI have launched a campaign to support a federal effort to honor patient participants in clinical trials. The effort is embodied in House Resolution 248, which encourages public recognition of clinical trial participants, and we need your help. For more information, click here. The August 2008 issue of IFAPP World, a publication of the International Federation of Associations of Pharmaceutical Physicians, is available for download here. The FDA is seeking comments on its "Draft Information Sheet Guidance for Sponsors, Clinical Investigators, and IRBs on Frequently Asked Questions – Statement of Investigator (Form FDA 1572); Availability" by September 29. For more information, click here. The 15th International Conference on Pharmaceutical Medicine (ICPM 2008), organized by the International Federation of Associations of Pharmaceutical Physicians, will be held in Amsterdam, The Netherlands, September 7–10. The deadline for nominations for the APPI Board of Trustees is August 29, 2008. For more information and a link to the nomination form, click here.

Print-Friendly Version RSS Search Back Issues Forward this Issue Subscribe Manage Your Subscription

News of Note from the APPI Leadership

Greg Koski is featured in IFAPP World and has succeeded Chris Allen on the IFAPP Executive Committee; Michael Koren has been appointed APPI Vice-President for Ethics and Professional Conduct....Read More

Medical Doctors Who Do Research Could be a Dying Breed

According to an editorial in Disease Models & Mechanisms, Britain's training programs may be contributing to the "lost tribe" of clinician-scientists—medical doctors who also perform laboratory research on disease....Read More

When Patients Can't Decide: Physician Perspectives on Surrogate Decision-Making

Family members are often called on to make medical choices for patients who are unable to do so themselves. In a recent study published in the Journal of Clinical Ethics, researchers studied how physicians treating these patients interacted with surrogate decision makers....Read More

U.K. Researchers and Colleagues Propose Novel Trial Design to Speed Drug Development

In the August 26 issue of the Journal of the National Cancer Institute, researchers from the United Kingdom, Canada, and the United States propose a novel multiarm trial design that can test several therapies simultaneously and could speed drug development in cancer....Read More

Huntington's Disease Treatment Finally Gains U.S. Approval

Already widely used to treat a major symptom of the incurable condition in other countries, the medicine's long path to U.S. approval for Huntington's started in the 1950s, when it was used for psychosis....Read More

Study Spotlights NIH Grant Outcomes for Clinical Research

Failure of applicants to adequately address human subject concerns is one reason clinical science grant applications to the National Institutes of Health (NIH) receive less positive peer reviews than basic science grant applications. Not submitting continuing, competitive renewal grant applications is another trouble spot....Read More

© 2007-2008 Academy of Pharmaceutical Physicians and Investigators. All Rights Reserved.

APPI is the voice of pharmaceutical physicians and physician investigators

Please send comments/questions about the Bulletin to gary@acrpnet.org

500 Montgomery Street, Suite 800 | Alexandria, VA 22314

To ensure delivery of the APPI Bulletin please add acrpnews@acrpnet.org to your e-mail address book or Safe Sender List. If you are still having problems receiving our communications, see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm

Click Here to unsubscribe